Bradford J. Duft
CoDa Therapeutics Co-Founder, Director, President and CEO
Before co-founding CoDa Therapeutics, Mr. Duft was a partner in the law firm Duane Morris. From 1990 through 1998, Mr. Duft was Senior Vice President and General Counsel of Amylin Pharmaceuticals. His 25 years in biotechnology has focused on biotechnology company strategy and growth, with an emphasis on deal-making and financing, intellectual property licensing, strategic patent prosecution, and litigation. In addition to experience in crafting and building U.S. and worldwide patent portfolios, Mr. Duft has drafted and negotiated numerous biotechnology agreements, including local and worldwide joint research agreements, joint development agreements and corporate partnership agreements, as well as numerous licenses.
Mr. Duft is a graduate of the George Washington University Law School, where he received a Masters in Patent and Trade Regulation, (LL.M., with highest honors), the California Western School of Law (J.D., cum laude), and the University of Colorado where he received his degree in Molecular, Cellular and Developmental Biology.
